These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 23075542

  • 1. Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?
    Latorre M, Baldini C, Seccia V, Notarstefano C, Della Rossa A, Tani C, Talarico R, Mosca M, Paggiaro PL.
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S91-2. PubMed ID: 23075542
    [No Abstract] [Full Text] [Related]

  • 2. Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?
    Cazzola M, Mura M, Segreti A, Mattei MA, Rogliani P.
    Allergy; 2009 Sep; 64(9):1389-90. PubMed ID: 19392997
    [No Abstract] [Full Text] [Related]

  • 3. Omalizumab in the treatment of asthma.
    Tan R, Corren J.
    Expert Rev Respir Med; 2011 Dec; 5(6):747-56. PubMed ID: 22082161
    [Abstract] [Full Text] [Related]

  • 4. Churg-Strauss vasculitis in a patient treated with omalizumab.
    Bargagli E, Madioni C, Olivieri C, Penza F, Rottoli P.
    J Asthma; 2008 Mar; 45(2):115-6. PubMed ID: 18350402
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Difficult asthma and Churg-Strauss-like syndrome: a cautionary tale.
    Lau EM, Cooper W, Bye PT, Yan K.
    Respirology; 2011 Jan; 16(1):180-1. PubMed ID: 21504509
    [No Abstract] [Full Text] [Related]

  • 8. Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
    Tzortzaki EG, Georgiou A, Kampas D, Lemessios M, Markatos M, Adamidi T, Samara K, Skoula G, Damianaki A, Schiza S, Tzanakis N, Siafakas NM.
    Pulm Pharmacol Ther; 2012 Feb; 25(1):77-82. PubMed ID: 22155001
    [Abstract] [Full Text] [Related]

  • 9. Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.
    Navarro-Mendoza EP, Tobón GJ.
    Curr Rheumatol Rep; 2018 Apr 02; 20(5):23. PubMed ID: 29611001
    [Abstract] [Full Text] [Related]

  • 10. Churg-strauss syndrome in patients treated with omalizumab.
    Wechsler ME, Wong DA, Miller MK, Lawrence-Miyasaki L.
    Chest; 2009 Aug 02; 136(2):507-518. PubMed ID: 19411292
    [Abstract] [Full Text] [Related]

  • 11. Allergic bronchopulmonary aspergillosis and omalizumab.
    Tillie-Leblond I, Germaud P, Leroyer C, Tétu L, Girard F, Devouassoux G, Grignet JP, Prudhomme A, Dusser D, Wallaert B.
    Allergy; 2011 Sep 02; 66(9):1254-6. PubMed ID: 21517902
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.
    Maselli DJ, Singh H, Diaz J, Peters JI.
    Ann Allergy Asthma Immunol; 2013 Jun 02; 110(6):457-61. PubMed ID: 23706716
    [Abstract] [Full Text] [Related]

  • 13. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.
    Jachiet M, Samson M, Cottin V, Kahn JE, Le Guenno G, Bonniaud P, Devilliers H, Bouillet L, Gondouin A, Makhlouf F, Meaux-Ruault N, Gil H, Bienvenu B, Coste A, Groh M, Giraud V, Dominique S, Godeau B, Puéchal X, Khouatra C, Ruivard M, Le Jeunne C, Mouthon L, Guillevin L, Terrier B, French Vasculitis Study Group.
    Arthritis Rheumatol; 2016 Sep 02; 68(9):2274-82. PubMed ID: 26946346
    [Abstract] [Full Text] [Related]

  • 14. Three months' administration of anti-IgE to a patient with Churg-Strauss syndrome.
    Giavina-Bianchi P, Giavina-Bianchi M, Agondi R, Kalil J.
    J Allergy Clin Immunol; 2007 May 02; 119(5):1279; author reply 1279-80. PubMed ID: 17349685
    [No Abstract] [Full Text] [Related]

  • 15. How do we interpret the data supporting the use of omalizumab for severe asthma?
    Lavietes MH.
    Ann Allergy Asthma Immunol; 2014 Oct 02; 113(4):335-6. PubMed ID: 25256024
    [No Abstract] [Full Text] [Related]

  • 16. Omalizumab administration in Churg-Strauss syndrome.
    Giavina-Bianchi P, Kalil J.
    Eur J Intern Med; 2009 Oct 02; 20(6):e139. PubMed ID: 19782907
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
    Raffray L, Guillevin L.
    Drugs; 2018 Jun 02; 78(8):809-821. PubMed ID: 29766394
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and safety of omalizumab in pre-filled syringes in patients with allergic (IgE-mediated) asthma.
    Somerville L, Bardelas J, Viegas A, D'Andrea P, Blogg M, Peachey G.
    Curr Med Res Opin; 2014 Jan 02; 30(1):59-66. PubMed ID: 24028677
    [Abstract] [Full Text] [Related]

  • 19. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM, QUALITX Study Investigators.
    J Asthma; 2012 Apr 02; 49(3):288-93. PubMed ID: 22356355
    [Abstract] [Full Text] [Related]

  • 20. Eligibility for treatment with omalizumab in Italy and Germany.
    Buhl R, Marco AG, Cohen D, Canonica GW.
    Respir Med; 2014 Jan 02; 108(1):50-6. PubMed ID: 24315468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.